| 臺大學術典藏 |
2021-01-12T12:49:14Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Hou H.-A.; Kuo Y.-Y.; Wu S.-J.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen C.-Y.; Chou W.-C.; Yao M.; SHANG-YI HUANG; Ko B.-S.; Tang J.-L.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:14Z |
Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010
|
Hsueh P.-R.; Chen C.-Y.; SHANG-YI HUANG; Tsay W.; Yao M.; Tang J.-L.; Ko B.-S.; Chou W.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:13Z |
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemia
|
Chen H.-Y.; Lai Y.-J.; Lin C.-W.; Cheng C.-L.; Hou H.-A.; Lee M.-C.; Liu C.-Y.; Jhuang J.-Y.; Liu F.-T.; Chou W.-C.; Chen C.-Y.; Tang J.-L.; Yao M.; SHANG-YI HUANG; Ko B.-S.; Wu S.-J.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:13Z |
Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia
|
Liu J.-H.; Sheng W.-H.; SHANG-YI HUANG; Chen C.-Y.; Cheng A.; Ko B.-S.; Yao M.; Chou W.-C.; Lin H.-C.; Chen Y.-C.; Tsay W.; Tang J.-L.; Chang S.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:12Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
SHANG-YI HUANG; Lin L.-I.; Yao M.; Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; Tang J.-L.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:12Z |
Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10
|
Chen C.-Y.; SHANG-YI HUANG; Tang J.-L.; Tsay W.; Yao M.; Ko B.-S.; Chou W.-C.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-12T12:49:11Z |
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
|
Tien H.-F.; Chen Y.-C.; Tsay W.; Wu S.-J.; Yang Y.-T.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; Kuo Y.-Y.; SHANG-YI HUANG; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Lin C.-T. |
| 臺大學術典藏 |
2021-01-12T12:49:11Z |
SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution
|
Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Wu S.-J.; Liu C.-Y.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; SHANG-YI HUANG; Hsu S.-C.; Ko B.-S.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:10Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Hou H.-A.; Tien H.-F.; Chen Y.-C.; Tsay W.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; SHANG-YI HUANG; Ko B.-S.; Wu S.-J. |
| 臺大學術典藏 |
2021-01-12T12:49:10Z |
Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations
|
Tien H.-F.; Chen Y.-C.; Tsay W.; Chou S.-C.; Tang J.-L.; Hou H.-A.; Chou W.-C.; Hu F.-C.; Chen C.-Y.; Yao M.; Ko B.-S.; SHANG-YI HUANG |
| 臺大學術典藏 |
2021-01-12T12:49:10Z |
Clinical implications of the SETBP1 mutation in patients with primary myelodysplastic syndrome and its stability during disease progression
|
Ko B.-S.; SHANG-YI HUANG; Liu C.-W.; Liu M.-C.; Chiang Y.-C.; Lee F.-Y.; Tseng M.-H.; Huang C.-F.; Hou H.-A.; Kuo Y.-Y.; Tang J.-L.; Chou W.-C.; Yao M.; Lai Y.-J.; Lin C.-C.; Chen C.-Y.; Liu C.-Y.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:09Z |
Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia
|
SHANG-YI HUANG; Yao M.; Liu M.-C.; Liu C.-W.; Chiang Y.-C.; Lee F.-Y.; Huang C.-F.; Tseng M.-H.; Chen C.-Y.; Chuang S.-S.; Lin C.-W.; Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:08Z |
TP53 mutations in de novo acute myeloid leukemia patients: Longitudinal follow-ups show the mutation is stable during disease evolution
|
Tseng M.-H.; Liu C.-Y.; Lin L.-I.; Kuo Y.-Y.; Chou W.-C.; Hou H.-A.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Li C.-C.; SHANG-YI HUANG; Ko B.-S.; Hsu S.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:08Z |
High incidences of invasive fungal infections in acute myeloid leukemia patients receiving induction chemotherapy without systemic antifungal prophylaxis: A prospective observational study in Taiwan
|
SHANG-YI HUANG; Hou H.-A.; Chou W.-C.; Wu S.-J.; Li C.-C.; Lin C.-T.; Hsu S.-C.; Wu U.-I.; Tang J.-L.; Kung H.-C.; Lei W.-C.; Yao M.; Tsay W.; Chen Y.-C.; Chen Y.-C.; Chang S.-C.; Ko B.-S.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:08Z |
Risk factors and clinical outcomes of acute myeloid leukaemia with central nervous system involvement in adults
|
Tsay W.; Wu S.-J.; Ko B.-S.; SHANG-YI HUANG; Yao M.; Chen C.-Y.; Chou W.-C.; Tang J.-L.; Lin C.-T.; Chang C.-H.; Fang W.-Q.; Hou H.-A.; Li C.-C.; Cheng C.-L.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:07Z |
GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution
|
Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Lin C.-C.; Kuo Y.-Y.; Hou H.-A.; Lin Y.-C.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; SHANG-YI HUANG; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:07Z |
Higher decorin levels in bone marrow plasma are associated with superior treatment response to novel agent-based induction in patients with newly diagnosed myeloma - A retrospective study
|
SHANG-YI HUANG; Lin H.-H.; Yao M.; Tang J.-L.; Wu S.-J.; Hou H.-A.; Chou W.-C.; Chou S.-C.; Hsu S.-C.; Ko B.-S.; Lu H.-Y.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:06Z |
Splicing factor mutations predict poor prognosis in patients with de novo acute myeloid leukemia
|
Hsu S.-C.; Ko B.-S.; SHANG-YI HUANG; Li C.-C.; Yao M.; Tang J.-L.; Liu C.-W.; Liu M.-C.; Hou H.-A.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Tsai C.-H.; Lin C.-C.; Lin L.-I.; Tseng M.-H.; Chiang Y.-C.; Chen C.-Y.; Lin C.-T.; Wu S.-J.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-12T12:49:06Z |
Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS)
|
Wu S.-J.; Kuo Y.-Y.; Liu C.-W.; Liu M.-C.; Chiang Y.-C.; Tseng M.-H.; Yao C.-Y.; Hou H.-A.; Lin T.-Y.; Lin C.-C.; Chou W.-C.; Liao X.-W.; Lin C.-T.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Li C.-C.; SHANG-YI HUANG; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:59:00Z |
Extramedullary relapse after all-trans retinoic acid treatment in acute promyelocytic leukemia - The occurrence of retinoic acid syndrome is a risk factor
|
Ko B.-S.; JIH-LUH TANG; Chen Y.-C.; Yao M.; Wang C.-H.; Shen M.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:59Z |
Philadelphia chromosome-positive acute lymphoblastic leukemia in Taiwan
|
Sheng M.-C.; Lin D.-T.; Lin K.-H.; Tien H.-F.; Wang C.-H.; Tsai W.; Chen Y.-C.; JIH-LUH TANG; Ko B.-S. |
| 臺大學術典藏 |
2021-01-06T03:58:56Z |
Additional chromosomal abnormalities and variability of BCR breakpoints in Philadelphia chromosome/BCR-ABL-positive acute lymphoblastic leukemia in Taiwan
|
Tsai W.; Chen Y.-C.; Wang C.-H.; Sheng M.-C.; Lin D.-T.; Lin K.-H.; Tien H.-F.; Ko B.-S.; JIH-LUH TANG; Lee F.-Y.; Liu M.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:54Z |
Reduction of leukocyte count is associated with thalidomide response in treatment of multiple myeloma
|
Huang S.-Y.; JIH-LUH TANG; Yao M.; Ko B.-S.; Hong R.-L.; Tsai W.; Wang C.-H.; Tien H.-F.; Shen M.-C.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:52Z |
Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome [1]
|
Lin D.-T.; Tien H.-F.; Chen C.-Y.; Lin L.-I.; JIH-LUH TANG; Tsay W.; Chang H.-H.; Yeh Y.-C.; Huang C.-F.; Chiou R.-J.; Yao M.; Ko B.-S.; Chen Y.-C.; Lin K.-H. |
| 臺大學術典藏 |
2021-01-06T03:58:48Z |
RUNX1 gene mutation in primary myelodysplastic syndrome - The mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome
|
Chen C.-Y.; Lin L.-I.; JIH-LUH TANG; Ko B.-S.; Tsay W.; Chou W.-C.; Yao M.; Wu S.-J.; Tseng M.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:47Z |
Comparison of hypoplastic myelodysplastic syndrome (MDS) with normo-/hypercellular MDS by International Prognostic Scoring System, cytogenetic and genetic studies
|
Huang T.-C.; Ko B.-S.; JIH-LUH TANG; Hsu C.; Chen C.-Y.; Tsay W.; Huang S.-Y.; Yao M.; Chen Y.-C.; Shen M.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:47Z |
Clinical characteristics and treatment response of Hodgkin's lymphoma in Taiwan
|
Wu S.-J.; Chen C.-Y.; Su I.-J.; JIH-LUH TANG; Chou W.-C.; Ko B.-S.; Huang S.-Y.; Yao M.; Tsay W.; Chen Y.-C.; Wang C.-H.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:45Z |
Poor outcome in post transplant lymphoproliferative disorder with pulmonary involvement after allogeneic hematopoietic SCT: 13 years' experience in a single institute
|
Hou H.-A.; Yao M.; JIH-LUH TANG; Chen Y.-K.; Ko B.-S.; Huang S.-Y.; Tien H.-F.; Chang H.-H.; Lu M.-Y.; Lin T.-T.; Lin K.-H.; Hsiao C.-H.; Lin C.-W.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:45Z |
Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients
|
Chou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; JIH-LUH TANG; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:44Z |
HLA-DR-matched parental donors for allogeneic hematopoietic stem cell transplantation in patients with high-risk acute leukemia
|
Wu S.-J.; Yao M.; JIH-LUH TANG; Ko B.-S.; Tien H.-F.; Chen Y.-C. |
| 臺大學術典藏 |
2021-01-06T03:58:43Z |
AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations
|
JIH-LUH TANG; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Lin L.-I.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:43Z |
Long-term outcome of allogeneic human leukocyte antigen-matched sibling-donor peripheral blood stem cell transplantation in leukaemia patients
|
JIH-LUH TANG; Yao M.; Lu M.Y.; Ko B.S.; Lin D.T.; Lin K.H.; Chen Y.C. |
| 臺大學術典藏 |
2021-01-06T03:58:42Z |
Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation
|
Liu M.-C.; Chou W.-C.; Hou H.-A.; Chen C.-Y.; JIH-LUH TANG; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:42Z |
WT1 mutation in 470 adult patients with acute myeloid leukemia: Stability during disease evolution and implication of its incorporation into a survival scoring system
|
Hou H.-A.; Huang T.-C.; Lin L.-I.; Liu C.-Y.; Chen C.-Y.; Chou W.-C.; JIH-LUH TANG; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:41Z |
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
|
Chou W.-C.; Huang H.-H.; Hou H.-A.; Chen C.-Y.; JIH-LUH TANG; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:40Z |
High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes
|
Cheng C.-L.; Hou H.-A.; Jhuang J.-Y.; Lin C.-W.; Chen C.-Y.; JIH-LUH TANG; Chou W.-C.; Tseng M.-H.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:40Z |
The prognostic impact and stability of Isocitrate dehydrogenase 2 mutation in adult patients with acute myeloid leukemia
|
Tseng M.-H.; Huang C.-F.; Tien H.-F.; Chou W.-C.; Lei W.-C.; Ko B.-S.; Hou H.-A.; Chen C.-Y.; JIH-LUH TANG; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W. |
| 臺大學術典藏 |
2021-01-06T03:58:39Z |
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics
|
Chou W.-C.; Chou S.-C.; Liu C.-Y.; Chen C.-Y.; Hou H.-A.; Kuo Y.-Y.; Lee M.-C.; Ko B.-S.; JIH-LUH TANG; Yao M.; Tsay W.; Wu S.-J.; Huang S.-Y.; Hsu S.-C.; Chen Y.-C.; Chang Y.-C.; Kuo Y.-Y.; Kuo K.-T.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:39Z |
DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications
|
Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:38Z |
The clinical implication of SRSF2 mutation in patients with myelodysplastic syndrome and its stability during disease evolution
|
Wu S.-J.; Kuo Y.-Y.; Hou H.-A.; Li Y.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Lin C.-T.; Chen C.-Y.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; JIH-LUH TANG; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:37Z |
Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010
|
Chen C.-Y.; Huang S.-Y.; Tsay W.; Yao M.; JIH-LUH TANG; Ko B.-S.; Chou W.-C.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-06T03:58:36Z |
Chromosomal abnormalities by conventional cytogenetics and interphase fluorescence in situ hybridization in chronic lymphocytic leukemia in Taiwan, an area with low incidence - Clinical implication and comparison between the West and the East
|
Wu S.-J.; Lin C.-T.; Huang S.-Y.; Lee F.-Y.; Liu M.-C.; Hou H.-A.; Chen C.-Y.; Ko B.-S.; Chou W.-C.; Yao M.; JIH-LUH TANG; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:36Z |
Clinical and Microbiological Characteristics of Perianal Infections in Adult Patients with Acute Leukemia
|
Chen C.-Y.; Cheng A.; Huang S.-Y.; Sheng W.-H.; Liu J.-H.; Ko B.-S.; Yao M.; Chou W.-C.; Lin H.-C.; Chen Y.-C.; Tsay W.; JIH-LUH TANG; Chang S.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:35Z |
Integration of cytogenetic and molecular alterations in risk stratification of 318 patients with de novo non-M3 acute myeloid leukemia
|
Hou H.-A.; Lin C.-C.; Chou W.-C.; Liu C.-Y.; Chen C.-Y.; JIH-LUH TANG; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Kuo Y.-Y.; Lee M.-C.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:35Z |
Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression
|
Wu S.-J.; JIH-LUH TANG; Lin C.-T.; Kuo Y.-Y.; Li L.-Y.; Tseng M.-H.; Huang C.-F.; Lai Y.-J.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Hou H.-A.; Chen C.-Y.; Chou W.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; Tsay W.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:35Z |
Clinical features of patients with infections caused by candida guilliermondii and candida fermentati and antifungal susceptibility of the isolates at a medical centre in taiwan, 2001-10
|
Chen C.-Y.; Huang S.-Y.; JIH-LUH TANG; Tsay W.; Yao M.; Ko B.-S.; Chou W.-C.; Tien H.-F.; Hsueh P.-R. |
| 臺大學術典藏 |
2021-01-06T03:58:34Z |
IPSS-R in 555 Taiwanese patients with primary MDS: Integration of monosomal karyotype can better risk-stratify the patients
|
Yang Y.-T.; Hou H.-A.; Liu C.-Y.; Lin C.-C.; Chou W.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Li C.-C.; Kuo Y.-Y.; Huang S.-Y.; Ko B.-S.; Chen C.-Y.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:34Z |
Guidelines for treating iron overload in myelodysplastic syndromes: A Taiwan consensus statement
|
Ko B.-S.; Chang C.-S.; Chang M.-C.; Chen T.Y.; Chiou T.-J.; Chiu C.-F.; Huang W.-L.; Kao W.-Y.; Lan Y.-J.; Lin S.-F.; Tan T.-D.; JIH-LUH TANG; Tzeng C.-H.; Wang P.-N.; Yet S.-P.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:33Z |
Prognostic implication of gene mutations on overall survival in the adult acute myeloid leukemia patients receiving or not receiving allogeneic hematopoietic stem cell transplantations
|
Chou S.-C.; JIH-LUH TANG; Hou H.-A.; Chou W.-C.; Hu F.-C.; Chen C.-Y.; Yao M.; Ko B.-S.; Huang S.-Y.; Tsay W.; Chen Y.-C.; Tien H.-F. |
| 臺大學術典藏 |
2021-01-06T03:58:32Z |
IDH mutations are closely associated with mutations of DNMT3A, ASXL1 and SRSF2 in patients with myelodysplastic syndromes and are stable during disease evolution
|
Lin C.-C.; Hou H.-A.; Chou W.-C.; Kuo Y.-Y.; Liu C.-Y.; Chen C.-Y.; Lai Y.-J.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; JIH-LUH TANG; Yao M.; Huang S.-Y.; Ko B.-S.; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. |
